🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,82 USD

Máx. histórico

178,74

2145 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,03%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,42%

Cierre anterior

17,57

Rango de hoy

17,52 – 18,77

Volumen hoy

2.596.193

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 14 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
21/06/2016 17,77 17,90 16,92 17,05 -4,48% 5,51% 3.494.400
20/06/2016 17,60 18,08 17,20 17,85 +2,82% 5,00% 2.379.100
17/06/2016 17,74 17,84 17,10 17,36 -0,12% 4,17% 3.470.800
16/06/2016 18,76 18,90 17,03 17,38 -7,90% 9,97% 4.180.300
15/06/2016 18,92 19,24 18,76 18,87 -1,10% 2,54% 2.451.000
14/06/2016 19,13 19,90 18,75 19,08 -1,70% 6,01% 2.985.800
13/06/2016 19,66 20,29 19,19 19,41 -2,71% 5,60% 3.445.600
10/06/2016 20,48 20,75 19,67 19,95 -4,95% 5,27% 3.756.200
09/06/2016 20,18 21,70 19,66 20,99 +7,97% 10,11% 13.748.200
08/06/2016 19,18 19,68 18,35 19,44 -1,17% 6,93% 7.219.000
07/06/2016 21,19 21,88 19,11 19,67 +22,55% 13,07% 18.936.200
06/06/2016 15,65 16,21 15,06 16,05 +3,08% 7,35% 4.659.700
03/06/2016 15,91 16,44 15,25 15,57 -0,89% 7,48% 6.057.900
02/06/2016 19,90 19,98 14,83 15,71 -26,62% 25,88% 20.697.900
01/06/2016 20,80 21,80 20,17 21,41 +2,29% 7,84% 4.080.900
31/05/2016 21,84 22,28 20,22 20,93 -1,23% 9,43% 6.882.600
27/05/2016 22,25 23,04 20,82 21,19 -4,55% 9,98% 6.599.500
26/05/2016 23,16 24,28 21,85 22,20 -4,93% 10,49% 8.478.800
25/05/2016 22,15 23,72 20,83 23,35 +26,63% 13,05% 21.334.700
24/05/2016 18,29 18,97 17,57 18,44 +5,49% 7,65% 5.558.300
23/05/2016 19,38 20,14 17,12 17,48 -8,72% 15,58% 7.159.100
20/05/2016 18,50 19,29 17,85 19,15 +8,81% 7,78% 7.477.200
19/05/2016 17,00 17,88 16,95 17,60 +2,86% 5,47% 2.403.600
18/05/2016 17,19 17,45 16,84 17,11 +0,18% 3,55% 1.520.900
17/05/2016 17,54 18,01 16,93 17,08 -3,28% 6,16% 2.862.700
16/05/2016 17,33 18,03 17,22 17,66 +2,79% 4,67% 3.092.600
13/05/2016 16,16 17,22 15,85 17,18 +5,72% 8,48% 2.197.200
12/05/2016 17,41 17,52 16,12 16,25 -7,30% 8,04% 2.653.200
11/05/2016 18,03 18,26 17,50 17,53 -1,24% 4,22% 2.240.400
10/05/2016 18,00 18,00 17,11 17,75 +0,68% 4,94% 2.664.000